Elucidating the angiopoietin-2-mediated vascular contributions to alzheimer's disease
Active Grant Awarded
- Award ID
- R01AG094837
- Recipient
-
The Trustees Of Columbia University In The City Of New York UEI QHF5ZZ114M72
- Awarding agency
-
National Institute on Aging
National Institutes of Health, Department of Health and Human Services
- Obligated
- $605,314
Award facts
- Assistance listing
- 93.866 Aging Research
- Completion date 4% complete
- Place of performance
- New York, NY 10032, USA
Award details come from USAspending.gov.
About this award
The Department of Health and Human Services, National Institutes of Health, National Institute on Aging awarded Grant R01AG094837 to The Trustees of Columbia University in the City of New York, doing business as Health Sciences Division, on September 9, 2026, with $605,314 obligated under the Aging Research program (CFDA 93.866). The grant funds research on angiopoietin-2 (ANGPT2) and vascular contributions to Alzheimer's disease, organized around three aims: defining ANGPT2's role in regulating blood-brain barrier integrity and neuroinflammation, assessing its contribution to Alzheimer's pathogenesis and progression, and elucidating the molecular mechanisms by which ANGPT2 drives neuroinflammation. The work integrates analyses of human Alzheimer's brain tissue with mechanistic studies in mouse models, including the 5XFAD model. Place of performance is New York, NY 10032, and the ultimate completion date is June 30, 2031. The Aging Research program supports biomedical, social, and behavioral research on the aging process, with particular emphasis on preventing and treating Alzheimer's disease and related dementias.
Description
- Abstract
- Alzheimer's disease (ad) is a progressive neurodegenerative disorder with limited therapeutic options, underscoring the urgent need for novel therapeutic targets. Growing evidence implicates neuroinflammation and blood-brain barrier (BBB) disruption as central contributors to ad pathogenesis and progression. Transcriptomic analysis of human ad brain samples revealed dysregulation of genes involved in vascular permeability, with angiopoietin-2 (ANGPT2) notably upregulated. ANGPT2, a ligand of the receptor tyrosine kinase TIE2, is a critical regulator of vascular permeability and angiogenesis. Our previous studies have shown that elevated ANGPT2 impairs TIE2 signaling, leading to vascular destabilization and leakage in inflammatory conditions and cancer. Our preliminary data from ANGPT2-modulating experiments in the 5XFAD mouse model-a well-established model of amyloid pathology-suggest that ANGPT2 contributes to BBB dysfunction, neuroinflammation, and ad progression. We hypothesize that ANGPT2 promotes BBB disruption and neuroinflammation, thereby accelerating ad pathogenesis. To test this, aim 1 will define the role of ANGPT2 in regulating BBB integrity and neuroinflammation in ad. Aim 2 will assess the contribution of ANGPT2 to ad pathogenesis and progression. Aim 3 will elucidate the molecular mechanisms by which ANGPT2 drives neuroinflammation. By integrating analyses of human ad tissues with mechanistic studies in mouse models, this research seeks to advance our understanding of BBB dysfunction in ad and uncover novel therapeutic targets.
Quick answers
Who received award R01AG094837?
R01AG094837 was awarded to The Trustees Of Columbia University In The City Of New York by National Institute on Aging (National Institutes of Health) on September 9, 2026.
How much is award R01AG094837 worth?
$605,314 has been obligated on R01AG094837.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award